# TRBCX (TRBCX)

> Source: Nexqual · https://nexqual.com/TRBCX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, TRBCX (TRBCX), nexqual.com/TRBCX" · informational, not investment advice.

**Price:** USD 207.91 (-0.66% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 207.91 · day 207.91–207.91 · 52w 179.68–227.75 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y -0.7% vs S&P 500 +13.4%; 5Y +43.6% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -0.7% | +43.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -0.7% | +7.5% |
| Volatility (annualized) | 18.5% | 22.1% |
| Max drawdown | -17.0% (Oct 2025→Mar 2026) | -42.7% (Nov 2021→Oct 2022) |

## Peers
RPMGX (T. Rowe Price Mid-Cap Growth Fu) USD 100.82 +0.00% · PRHSX (T. Rowe Price Health Sciences F) USD 97.06 +0.00% · PRFDX (T. Rowe Price Equity Income Fd) USD 45.64 +0.00% · PRSCX (T. Rowe Price Science and Techn) USD 67.49 +0.00% · PRNHX (T. Rowe Price New Horizons Fund) USD 54.9 -0.00%

## More
Full page: https://nexqual.com/TRBCX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt